Published in Drug Week, September 2nd, 2005
The offering price of $3.43 was determined by applying a 15% discount to the 5-day trailing average closing price of Pharmacopeia common stock of $4.04.
Jefferies & Company, Inc., acted as financial advisor and sole placement agent to Pharmacopeia for the transaction.
The securities sold in this private placement have not been registered under the Securities Act of 1933,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.